Clinical Trial: Extension Study of Long-term Safety and Efficacy of Myozyme for a Single Patient With Pompe Disease Who Were Previously Enrolled in Genzyme Sponsored ERT Studies.
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: An Open-Label Extension Study of the Long-Term Safety and Efficacy of Recombinant Human Acid α-Glucosidase (rhGAA) Given as Enyzme Replacement Therapy to a Single Patient With Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Sanofi
Dates:
Date Received: October 2, 2008
Date Started: April 2003
Date Completion:
Last Updated: February 4, 2014
Last Verified: February 2014